{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:20:57Z","timestamp":1787502057856,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00508-023-02278-1","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T12:02:18Z","timestamp":1696852938000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin resistance is a\u00a0cardiovascular risk factor in hypertensive adults without type\u00a02 diabetes mellitus"],"prefix":"10.1007","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-4585","authenticated-orcid":false,"given":"Rafael","family":"Garcia-Carretero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Vazquez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5229-3832","authenticated-orcid":false,"given":"Ruth","family":"Gil-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1295-7101","authenticated-orcid":false,"given":"Angel","family":"Gil-de-Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"issue":"11","key":"2278_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","volume":"22","author":"DE James","year":"2021","unstructured":"James\u00a0DE, St\u00f6ckli\u00a0J, Birnbaum\u00a0MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751\u201371. Nov.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2278_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso\u00a0M, Kuusisto\u00a0J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293\u2013302. May.","journal-title":"Nat Rev Endocrinol"},{"key":"2278_CR3","doi-asserted-by":"crossref","unstructured":"Fonseca VA. Defining and characterizing the progression of type\u00a02 diabetes. Diabetes care. 2009 Nov;32 Suppl 2:S151\u20136.","DOI":"10.2337\/dc09-S301"},{"issue":"1","key":"2278_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2337\/diacare.24.1.89","volume":"24","author":"C Weyer","year":"2001","unstructured":"Weyer C, Tataranni PA, Bogardus C, Pratley RE. Insulin Resistance and Insulin Secretory Dysfunction Are Independent Predictors of Worsening of Glucose Tolerance During Each Stage of Type 2 Diabetes Development. Diabetes Care. 2001;24(1):89\u201394.","journal-title":"Diabetes Care."},{"issue":"11","key":"2278_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"UKPDS","year":"1995","unstructured":"UKPDS. U.K. Prospective Diabetes Study 16: Overview of 6 Years\u2019 Therapy of Type II Diabetes: A Progressive Disease. Diabetes. 1995;44(11):1249\u201358.","journal-title":"Diabetes."},{"issue":"1","key":"2278_CR6","first-page":"1","volume":"6;7","author":"M Li","year":"2022","unstructured":"Li\u00a0M, Chi\u00a0X, Wang\u00a0Y, Setrerrahmane\u00a0S, Xie\u00a0W, Xu\u00a0H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Sig Transduct Target Ther. 2022;6;7(1):1\u201325. Jul.","journal-title":"Sig Transduct Target Ther"},{"issue":"6","key":"2278_CR7","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/db16-0152","volume":"65","author":"GL King","year":"2016","unstructured":"King\u00a0GL, Park\u00a0K, Li\u00a0Q. Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture. Diabetes. 2016;65(6):1462\u201371. Jun.","journal-title":"Diabetes"},{"issue":"1","key":"2278_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"31;17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal\u00a0V, Nair\u00a0S, Elfeky\u00a0O, Aguayo\u00a0C, Salomon\u00a0C, Zu\u00f1iga\u00a0FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;31;17(1):122. Aug.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2278_CR9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","volume":"32","author":"G Reaven","year":"2012","unstructured":"Reaven\u00a0G. Insulin resistance and coronary heart disease in nondiabetic individuals. Arterioscler Thromb Vasc Biol. 2012;32(8):1754\u20139. Aug.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2278_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s00125-005-1711-9","volume":"48","author":"B Zethelius","year":"2005","unstructured":"Zethelius\u00a0B, Lithell\u00a0H, Hales\u00a0CN, Berne\u00a0C. Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A\u00a0population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia. 2005;48(5):862\u20137. May.","journal-title":"Diabetologia"},{"issue":"8","key":"2278_CR11","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.2337\/dc22-0202","volume":"45","author":"T Wang","year":"2022","unstructured":"Wang\u00a0T, Li\u00a0M, Zeng\u00a0T, Hu\u00a0R, Xu\u00a0Y, Xu\u00a0M, et\u00a0al. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A\u00a0Nationwide Prospective Cohort Study. Diabetes Care. 2022;45(8):1863\u201372. Aug.","journal-title":"Diabetes Care"},{"issue":"4","key":"2278_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS Ellulu","year":"2017","unstructured":"Ellulu\u00a0MS, Patimah\u00a0I, Khaza\u2019ai\u00a0H, Rahmat\u00a0A, Abed\u00a0Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851\u201363. Jun.","journal-title":"Arch Med Sci"},{"issue":"2","key":"2278_CR13","first-page":"148","volume":"30","author":"E Scarpellini","year":"2012","unstructured":"Scarpellini\u00a0E, Tack\u00a0J. Obesity and Metabolic Syndrome: An Inflammatory. Cond Ddi. 2012;30(2):148\u201353.","journal-title":"Cond Ddi"},{"key":"2278_CR14","doi-asserted-by":"publisher","unstructured":"Garcia-Carretero R, Vigil-Medina L, Barquero-Perez O. The Use of Machine Learning Techniques to Determine the Predictive Value of Inflammatory Biomarkers in the Development of Type\u00a02 Diabetes Mellitus. Metabolic Syndrome and Related Disorders [Internet]. 2021 Feb 16; Available from: https:\/\/doi.org\/10.1089\/met.2020.0139","DOI":"10.1089\/met.2020.0139"},{"issue":"5","key":"2278_CR15","doi-asserted-by":"publisher","first-page":"e1000278","DOI":"10.1371\/journal.pmed.1000278","volume":"7","author":"N Sarwar","year":"2010","unstructured":"Sarwar\u00a0N, Aspelund\u00a0T, Eiriksdottir\u00a0G, Gobin\u00a0R, Seshasai\u00a0SRK, Forouhi\u00a0NG, et\u00a0al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. Plos Med. 2010;7(5):e1000278. May.","journal-title":"Plos Med"},{"issue":"7121","key":"2278_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"14;444","author":"SE Kahn","year":"2006","unstructured":"Kahn\u00a0SE, Hull\u00a0RL, Utzschneider\u00a0KM. Mechanisms linking obesity to insulin resistance and type\u00a02 diabetes. Nature. 2006;14;444(7121):840\u20136. Dec.","journal-title":"Nature"},{"issue":"9","key":"2278_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey\u00a0AS, Stevens\u00a0LA, Schmid\u00a0CH, Zhang\u00a0YL, Castro\u00a0AF, Feldman\u00a0HI, et\u00a0al. A\u00a0new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2278_CR18","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger\u00a0T, Borghi\u00a0C, Charchar\u00a0F, Khan\u00a0NA, Poulter\u00a0NR, Prabhakaran\u00a0D, et\u00a0al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334\u201357. Jun.","journal-title":"Hypertension"},{"key":"2278_CR19","doi-asserted-by":"crossref","unstructured":"Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes\u20142018. Diabetes Care. 2018 Jan 1;41(Supplement 1):S13 LP\u2013S27.","DOI":"10.2337\/dc18-S002"},{"key":"2278_CR20","doi-asserted-by":"crossref","unstructured":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA. 2001 May 16;285(19):2486\u201397.","DOI":"10.1001\/jama.285.19.2486"},{"key":"2278_CR21","volume-title":"A\u00a0Language and Environment for Statistical Computing [Internet]. Vienna, Austria","author":"R Core Team","year":"2020","unstructured":"R Core Team. A\u00a0Language and Environment for Statistical Computing [Internet]. Vienna, Austria. Available from: https:\/\/www.r-project.org: R Foundation for Statistical Computing; 2020."},{"issue":"3","key":"2278_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/sj.bjc.6601119","volume":"4;89","author":"MJ Bradburn","year":"2003","unstructured":"Bradburn\u00a0MJ, Clark\u00a0TG, Love\u00a0SB, Altman\u00a0DG. Survival analysis part II: multivariate data analysis\u2014an introduction to concepts and methods. Br J Cancer. 2003;4;89(3):431\u20136. Aug.","journal-title":"Br J Cancer"},{"issue":"2","key":"2278_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/sj.bjc.6601118","volume":"89","author":"TG Clark","year":"2003","unstructured":"Clark\u00a0TG, Bradburn\u00a0MJ, Love\u00a0SB, Altman\u00a0DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89(2):232\u20138. Jul.","journal-title":"Br J Cancer"},{"key":"2278_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.12688\/wellcomeopenres.15191.1","volume":"1;4","author":"M Allen","year":"2019","unstructured":"Allen\u00a0M, Poggiali\u00a0D, Whitaker\u00a0K, Marshall\u00a0TR, Kievit\u00a0RA. Raincloud plots: a\u00a0multi-platform tool for robust data visualization. Wellcome Open Res. 2019;1;4:63\u201363. Apr.","journal-title":"Wellcome Open Res"},{"issue":"9","key":"2278_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1055\/s-2002-34788","volume":"34","author":"HM Lakka","year":"2002","unstructured":"Lakka\u00a0HM, Salonen\u00a0JT, Tuomilehto\u00a0J, Kaplan\u00a0GA, Lakka\u00a0TA. Obesity and weight gain are associated with increased incidence of hyperinsulinemia in non-diabetic men. Horm Metab Res. 2002;34(9):492\u20138. Sep.","journal-title":"Horm Metab Res"},{"issue":"1","key":"2278_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11684-013-0262-6","volume":"7","author":"J Ye","year":"2013","unstructured":"Ye\u00a0J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14\u201324. Mar.","journal-title":"Front Med"},{"issue":"1","key":"2278_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/187153007780059423","volume":"7","author":"J Ye","year":"2007","unstructured":"Ye\u00a0J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr Metab Immune Disord Drug Targets. 2007;7(1):65\u201374. Mar.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"5","key":"2278_CR28","doi-asserted-by":"publisher","first-page":"E466","DOI":"10.1152\/ajpendo.00266.2012","volume":"304","author":"J Ye","year":"2013","unstructured":"Ye\u00a0J, McGuinness\u00a0OP. Inflammation during obesity is not all bad: evidence from animal and human studies. Am J Physiol Endocrinol Metab. 2013;304(5):E466\u201377. Mar.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"2278_CR29","doi-asserted-by":"publisher","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","volume":"288","author":"DCW Lau","year":"2005","unstructured":"Lau\u00a0DCW, Dhillon\u00a0B, Yan\u00a0H, Szmitko\u00a0PE, Adipokines\u00a0VS. molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005;288(5):H2031\u201341. May.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"2278_CR30","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","volume":"46","author":"S Cinti","year":"2005","unstructured":"Cinti\u00a0S, Mitchell\u00a0G, Barbatelli\u00a0G, Murano\u00a0I, Ceresi\u00a0E, Faloia\u00a0E, et\u00a0al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J\u00a0Lipid Res. 2005;46(11):2347\u201355. Nov.","journal-title":"J Lipid Res"},{"key":"2278_CR31","doi-asserted-by":"crossref","unstructured":"Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinology and metabolism clinics of North America. 2008 Sep;37(3):753\u201368, x\u2013xi.","DOI":"10.1016\/j.ecl.2008.07.002"},{"key":"2278_CR32","doi-asserted-by":"crossref","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et\u00a0al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735\u201352.","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"2278_CR33","doi-asserted-by":"crossref","unstructured":"Alberti K, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et\u00a0al. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International A. Circulation. 2009;120(16):1640\u20135.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"issue":"33","key":"2278_CR34","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2174\/138161211798220882","volume":"17","author":"M Haidara","year":"2011","unstructured":"Haidara\u00a0M, Mikhailidis\u00a0DP, Yassin\u00a0HZ, Dobutovic\u00a0B, Smiljanic\u00a0KT, Soskic\u00a0S, et\u00a0al. Evaluation of the possible contribution of antioxidants administration in metabolic syndrome. Curr Pharm Des. 2011;17(33):3699\u2013712. Nov.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"2278_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/1570161114666161007164510","volume":"15","author":"Z Gluvic","year":"2017","unstructured":"Gluvic\u00a0Z, Zaric\u00a0B, Resanovic\u00a0I, Obradovic\u00a0M, Mitrovic\u00a0A, Radak\u00a0D, et\u00a0al. Link between Metabolic Syndrome and Insulin Resistance. Curr Vasc Pharmacol. 2017;15(1):30\u20139.","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"2278_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/0003319714528569","volume":"66","author":"E Stoki\u0107","year":"2015","unstructured":"Stoki\u0107\u00a0E, Kupusinac\u00a0A, Tomi\u0107-Nagli\u0107\u00a0D, Zavi\u0161i\u0107\u00a0BK, Mitrovi\u0107\u00a0M, Smiljeni\u0107\u00a0D, et al. Obesity and vitamin D deficiency: trends to promote a\u00a0more proatherogenic cardiometabolic risk profile. Angiology. 2015;66(3):237\u201343. Mar.","journal-title":"Angiology"},{"issue":"9709","key":"2278_CR37","first-page":"132","volume":"9;375","author":"S Kaptoge","year":"2010","unstructured":"Emerging Risk Factors Collaboration, Kaptoge\u00a0S, Di Angelantonio\u00a0E, Lowe\u00a0G, Pepys\u00a0MB, Thompson\u00a0SG, et al. C\u2011reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;9;375(9709):132\u201340. Jan.","journal-title":"Lancet"},{"issue":"1","key":"2278_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","volume":"8;118","author":"PM Ridker","year":"2016","unstructured":"Ridker\u00a0PM. From C\u2011Reactive Protein to Interleukin\u20116 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res. 2016;8;118(1):145\u201356. Jan.","journal-title":"Circ Res"},{"issue":"7","key":"2278_CR39","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo\u00a0RA. Insulin resistance, lipotoxicity, type\u00a02 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53(7):1270\u201387. Jul.","journal-title":"Diabetologia"},{"issue":"7","key":"2278_CR40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"1;28","author":"DR Matthews","year":"1985","unstructured":"Matthews\u00a0DR, Hosker\u00a0JP, Rudenski\u00a0AS, Naylor\u00a0BA, Treacher\u00a0DF, Turner\u00a0RC. Homeostasis model assessment: insulin resistance and \u03b2\u2011cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;1;28(7):412\u20139. Jul.","journal-title":"Diabetologia"},{"issue":"2","key":"2278_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2337\/diabetes.54.2.333","volume":"54","author":"SE Stern","year":"2005","unstructured":"Stern\u00a0SE, Williams\u00a0K, Ferrannini\u00a0E, DeFronzo\u00a0RA, Bogardus\u00a0C, Stern\u00a0MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54(2):333\u20139. Feb.","journal-title":"Diabetes"},{"key":"2278_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1472-6823-13-47","volume":"16;13","author":"P Gayoso-Diz","year":"2013","unstructured":"Gayoso-Diz\u00a0P, Otero-Gonz\u00e1lez\u00a0A, Rodriguez-Alvarez\u00a0MX, Gude\u00a0F, Garc\u00eda\u00a0F, De Francisco\u00a0A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a\u00a0general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 2013;16;13:47. Oct.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2278_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.beem.2006.07.002","volume":"20","author":"V Lamounier-Zepter","year":"2006","unstructured":"Lamounier-Zepter\u00a0V, Ehrhart-Bornstein\u00a0M, Bornstein\u00a0SR. Insulin resistance in hypertension and cardiovascular disease. Best Pract Res Clin Endocrinol Metab. 2006;20(3):355\u201367. Sep.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2278_CR44","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2337\/dc08-0854","volume":"32","author":"D Eddy","year":"2009","unstructured":"Eddy\u00a0D, Schlessinger\u00a0L, Kahn\u00a0R, Peskin\u00a0B, Schiebinger\u00a0R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a\u00a0mathematical analysis. Diabetes Care. 2009;32(2):361\u20136. Feb.","journal-title":"Diabetes Care"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-023-02278-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-023-02278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T08:12:54Z","timestamp":1706861574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-023-02278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":44,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2278"],"URL":"https:\/\/doi.org\/10.1007\/s00508-023-02278-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.\u00a0Garcia-Carretero, O.\u00a0Vazquez-Gomez, R.\u00a0Gil-Prieto and A.\u00a0Gil-de-Miguel declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study was approved by the Research and Ethics Committee of Mostoles University Hospital. All procedures involving human participants were conducted in accordance with the ethical standards of the responsible institutional and\/or National Research Committee and with the tenets of the 1964 Helsinki Declaration and its later amendments and comparable ethical standards. The authors obtained consent for publication from their institution and its Research and Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}